Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
Rocco VergalloLeonarda GaliutoPublished in: European heart journal (2024)
Keyphrases
- thoracic surgery
- atrial fibrillation
- oxidative stress
- left ventricular
- catheter ablation
- oral anticoagulants
- left atrial
- cancer therapy
- left atrial appendage
- heart failure
- direct oral anticoagulants
- percutaneous coronary intervention
- drug delivery
- coronary artery disease
- mitral valve
- acute coronary syndrome
- venous thromboembolism